Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


AAIC: Metformin Treatment Linked to Lower Dementia Risk
Initiating treatment with sulfonylureas, thiazolidinediones, and insulin does not lower risk
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

September 1, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Modest Predictive Accuracy for CHA2DS2-VASc in Heart Failure

Multidisciplinary Rehab Tops CBT for Chronic Fatigue Syndrome

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use

Periodontal Disease Predicts CAC Progression in Type 1 Diabetes

FDA Approves Repatha for Certain Patients With High Cholesterol